Catalyst Wire Dossier Catalyst Wire Dossier

CARDENE IV

nicardipine hydrochloride · Baxter Healthcare Corporation
Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for CARDENE IV, covering 2007-06-22 to 2026-03-27. Get the full timeline:

Most recent: FDA Approved: CARDENE IV — Supplemental Application (Baxter Healthcare Corporation)

See pricing